HWKNBasic Materials · Specialty ChemicalsThe 3 Wall Street analysts covering Hawkins, Inc. hold a median 12-month price target of $178 — +33.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 65 of 100 as at 22 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Hawkins, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (93): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (39): The shares have been drifting down relative to others.
Size (31): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on HWKN, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +33.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Oct 2026 | Barclays | Maintains | Equal-Weight | $142 → $141 |
| 3 Aug 2026 | BWS Financial | Maintains | Buy | $200 |
| 3 Aug 2026 | BWS Financial | Maintains | Buy | — |
| 31 July 2026 | Barclays | Maintains | Equal-Weight | $170 → $142 |
| 31 July 2026 | Barclays | Maintains | Equal-Weight | — |
| 30 June 2026 | Barclays | Initiates | Equal-Weight | $170 |
| 30 June 2026 | Barclays | Initiates | Equal-Weight | — |
| 23 Mar 2026 | BWS Financial | Maintains | Buy | — |
| 29 Jan 2026 | BWS Financial | Maintains | Buy | — |
| 3 Nov 2025 | BWS Financial | Maintains | Buy | — |
| 1 Aug 2025 | BWS Financial | Maintains | Buy | — |
| 24 July 2025 | Raymond James | Initiates | Market Perform | — |
| 15 May 2025 | BWS Financial | Maintains | Buy | — |
| 14 Apr 2025 | BWS Financial | Upgrade | Buy | — |
| 31 Jan 2025 | BWS Financial | Maintains | Neutral | — |
| 31 Oct 2024 | BWS Financial | Maintains | Neutral | — |
| 16 Oct 2024 | BWS Financial | Downgrade | Neutral | — |
| 17 May 2024 | BWS Financial | Maintains | Buy | — |
| 3 Nov 2023 | BWS Financial | Maintains | Buy | — |
| 7 Aug 2023 | BWS Financial | Upgrade | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
HWKN appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 22 Oct 2026, Hawkins, Inc. returned −18.0% against +15.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 22% of US stocks
Cheaper than 46% of US stocks
Cheaper than 19% of US stocks
Cheaper than 18% of US stocks
Higher than 46% of US stocks
Higher than 33% of US stocks
Higher than 25% of US stocks
Higher than 68% of US stocks
Higher than 65% of US stocks
Higher than 75% of US stocks
Higher than 85% of US stocks
Higher than 67% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Hawkins, Inc. has a market value of $2.7B and an enterprise value of $3.0B.
Revenue in the twelve months to 30 June 2026: $1.1B. The latest quarter grew 7.6% year on year.
Net income over the same four quarters: $80.6M, a 7.3% net margin.
Diluted earnings per share, trailing twelve months: $3.86.
Free cash flow in the twelve months to 30 June 2026: $91.7M.
Hawkins, Inc. spent $10.0M on share buybacks and $15.9M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 33.9×; forward P/E: 27.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.61%, paying out 20% of earnings.
Hawkins, Inc. employs 1,200 people — $922K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Hawkins, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research compares Axalta Coating Systems and Hawkins as specialty chemical stocks, framing the article around which may be an undervalued option for investors.
Why it matters — The article puts Hawkins in a valuation-focused comparison with Axalta, relevant to readers following HWKN.
Hawkins, Inc. announced it will release its second quarter fiscal 2027 financial results, covering the period ended September 27, 2026, after market close on October 26, 2026 at approximately 4:10 p.m.
Why it matters — This sets the date for the company's upcoming quarterly earnings disclosure, which HWKN watchers will look to for the latest financial performance update.
Hawkins, Inc. expanded its Texas water treatment operations through the acquisition of Eagle Labs, adding two facilities and strengthening its Dallas-Fort Worth presence.
Why it matters — A HWKN watcher would care because this acquisition grows the company's water treatment footprint and regional operational capacity in Texas.
Zacks Investment Research compares Axalta Coating Systems (AXTA) and Hawkins (HWKN) as value stock candidates in the Chemical - Specialty sector, examining which is more attractive to value investors. The article evaluates both companies' characteristics from a value investing perspective.
Why it matters — The analysis provides Hawkins watchers with a comparative value-focused assessment of the stock against a peer in the specialty chemicals space.
Hawkins, Inc. completed the acquisition of the assets of Eagle Labs, Inc., a water treatment products distributor with in-house manufacturing capabilities operating in Texas' Dallas–Fort Worth region. The acquisition expands Hawkins' footprint into that Texas market, where Eagle Labs distributes water treatment products directly to customers.
Why it matters — HWKN watchers would care because the deal expands the company's geographic reach into the Dallas–Fort Worth region and adds in-house manufacturing capabilities to its water treatment business.
The 3 Wall Street analysts covering Hawkins, Inc. have a median 12-month price target of $178, with estimates ranging from $141 to $200. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 3 analysts covering Hawkins, Inc., 2 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Hawkins, Inc. 65 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Oct 2026, Hawkins, Inc. ranks 65 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (93 of 100).
No one can know that. What the data says: the median 12-month target from 3 analysts implies +33.3% from the last close, and Ticker Nerd's factor model ranks Hawkins, Inc. 65 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Hawkins, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HWKN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $141 to $200 over the next 12 months.
Hawkins, Inc. returned -18.0% over the 12 months to 22 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Hawkins, Inc. is a specialty chemical and water treatment company that formulates, manufactures, distributes, and blends products for a broad range of industrial and commercial customers.
The most recent item we track (Zacks Investment Research, 15 Oct 2026): "AXTA vs. HWKN: Which Stock Should Value Investors Buy Now?". Zacks Investment Research compares Axalta Coating Systems and Hawkins as specialty chemical stocks, framing the article around which may be an undervalued option for investors.
Hawkins, Inc. is a specialty chemical and water treatment company that formulates, manufactures, distributes, and blends products for a broad range of industrial and commercial customers. Hawkins serves three core business segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. Its Water Treatment segment provides chemicals, equipment, and related solutions for potable water, wastewater, process water, and pool applications. The Food and Health Sciences business supplies ingredients and formulation solutions for food, beverage, nutraceutical, dietary supplement, and personal care manufacturers. Industrial Solutions delivers chemicals and services used in sectors such as agriculture, energy, electronics, pharmaceutical, and chemical processing. Hawkins, Inc. is headquartered in Roseville, Minnesota, and focuses on products and services that support essential operations across water, food, health, and industrial markets.
CEO Mr. Patrick H. Hawkins · 1,200 employees · United States · https://www.hawkinsinc.com
